Rani Therapeutics
(NASDAQ) RANI
Rani Therapeutics Financials at a Glance
Market Cap
$81.53M
Revenue (TTM)
$1.63M
Net Income (TTM)
$29.67M
EPS (TTM)
$-0.59
P/E Ratio
-1.39
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.81
Volume
612,722.342
Open
$0.82
Price
$0.81
Volume
612,722.342
Open
$0.82
Previous Close
$0.82
Daily Range
$0.78 - $0.82
52-Week Range
$0.39 - $3.87
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.81
Volume
612,722.342
Open
$0.82
Previous Close
$0.82
Daily Range
$0.78 - $0.82
52-Week Range
$0.39 - $3.87
RANI News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rani Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
71
CEO
Talat Imran
Website
www.ranitherapeutics.comHeadquarters
San Jose, CA 95131, US
RANI Financials
Key Financial Metrics (TTM)
Gross Margin
75%
Operating Margin
-23%
Net Income Margin
-18%
Return on Equity
-170%
Return on Capital
-83%
Return on Assets
-51%
Earnings Yield
-71.94%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$81.53M
Shares Outstanding
99.72M
Volume
612.72K
Short Interest
0.00%
Avg. Volume
1.15M
Financials (TTM)
Gross Profit
$733.00K
Operating Income
$38.31M
EBITDA
$37.41M
Operating Cash Flow
$18.71M
Capital Expenditure
$88.00K
Free Cash Flow
$18.80M
Cash & ST Invst.
$49.71M
Total Debt
$4.32M
Rani Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.46M
+42.1%
Gross Profit
$1.27M
+24.0%
Gross Margin
87.27%
N/A
Market Cap
$81.53M
N/A
Market Cap/Employee
$776.50K
N/A
Employees
105
N/A
Net Income
$10.31M
-15.2%
EBITDA
$8.79M
+38.6%
Quarterly Fundamentals
Net Cash
$45.39M
+2292.8%
Accounts Receivable
$2.04M
+377.1%
Inventory
$0.00
N/A
Long Term Debt
$2.73M
-79.4%
Short Term Debt
$1.59M
-90.4%
Return on Assets
-50.62%
N/A
Return on Invested Capital
-83.37%
N/A
Free Cash Flow
$294.00K
+103.4%
Operating Cash Flow
$294.00K
+103.4%